Ouzama Henry

Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus Vaccine (RSVPreF3) in Mothers and Their Infants: A Phase 2 Randomized Trial

Zourab Bebia, Osvaldo Reyes, Robert Jeanfreau et al. · The Journal of Infectious Diseases · 2023 · 60 citations · Full text

Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in pregnant women and their infants: Results from a randomized placebo-controlled phase II trial

Geeta K. Swamy, Torri D. Metz, Kathryn M. Edwards et al. · Vaccine · 2020 · 59 citations · Full text

Three Dose Levels of a Maternal Respiratory Syncytial Virus Vaccine Candidate Are Well Tolerated and Immunogenic in a Randomized Trial in Nonpregnant Women

Tino F. Schwarz, Casey Johnson, Christine Grigat et al. · The Journal of Infectious Diseases · 2021 · 43 citations · Full text

Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trial

Michael Povey, Ouzama Henry, Marianne A. Riise Bergsaker et al. · The Lancet Infectious Diseases · 2019 · 42 citations

Vaccination, Vaccine Safety, Monovalent Varicella Vaccine +7

Immunogenicity and safety of a second dose of a measles-mumps-rubella vaccine administered to healthy participants 7 years of age or older: A phase III, randomized study

Remon Abu‐Elyazeed, William Jennings, Randall Severance et al. · Human Vaccines & Immunotherapeutics · 2018 · 37 citations · Full text